Pfizer, Moderna, Schwab, Instacart, D.R. Horton, Tesla, and More Stock Market Movers

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Pfizer slashes revenue expectations, Charles Schwab's adjusted earnings beat estimates, and Lululemon will be joining the S&P 500 on Wednesday.

Stocks traded higher Monday as Wall Street prepared for a busy week of corporate earnings, with reports from Tesla and Netflix among the highlights. Traders also continued to monitor developments in the Israel-Hamas war.Pfizer slashed revenue expectations for the year to $58 billion to $61 billion, down from a previous outlook of $67 billion to $70 billion as the drug maker expects a drop in sales of $9 billion from its Covid-19 vaccine and anti-viral treatment Paxlovid.

Charles Schwab , the largest publicly traded U.S. brokerage, reported third-quarter adjusted earnings of 77 cents a share, beating analysts’ estimates of 74 cents. Revenue fell 6% to $4.61 billion. The stock was up 4.2%. Alignment Healthcare jumped 20% to $7.97 after shares of the provider of health care services for seniors were upgraded to Strong Buy from Outperform at Raymond James and the price target was raised to $10 from $9.

Starboard Value has built a stake in News Corp and the activist shareholder plans to push for strategic and governance changes, The Wall Street Journal reported, citing people familiar with the matter. Starboard’s stake in News Corp is “sizeable,” the people said. News Corp is the owner of Dow Jones, which publishes the Journal, Barron’s, and MarketWatch. News Corp’s class A shares rose 2.9%.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 3. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
출처: ForbesTech - 🏆 318. / 59 더 많은 것을 읽으십시오 »

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
출처: Forbes - 🏆 394. / 53 더 많은 것을 읽으십시오 »